PUBLIC CONTRACT · 2017
FEXC0057/2017 - Ipilimumab 200 mg (5MG/ml AMP 40 ml) sol inj;ipilimumab 50 mg (5MG/ml AMP 40 ml) sol inj
- Contract value
- €14,875.00
- Signed on
- 13 June 2017
- Procedure
- Direct award, general (Ajuste Direto Regime Geral)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 4359367PUBLISHED DESCRIPTION
FEXC0075/2017 - IPILIMUMAB 200 MG (5MG/ML AMP 40 ML) SOL INJ;IPILIMUMAB 50 MG (5MG/ML AMP 40 ML) SOL INJ
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Setúbal, Barreiro
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- BRISTOL MYERS SQUIBB-FARM. POR · Tax ID 500048193
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €14,875.00
- Procedure base price
- €14,875.00
- Total effective price
- €14,875.00
- Publication date
- 19 March 2018
- Award date
- 13 June 2017
- Signing date
- 13 June 2017
- Performance period
- 20 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Direct award, general (Ajuste Direto Regime Geral)
- Award criterion
- Not stated
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 24.º, n.º 1, alínea e) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL 18/2008)
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 3336108
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.